GeneDx Holdings Corp. Restructuring and Related Cost, Number of Positions Eliminated
GeneDx Holdings Corp. (WGS) reported Restructuring and Related Cost, Number of Positions Eliminated of 75 position for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminated · last filed 2026-08-03
- GeneDx Holdings Corp. restructuring and related cost, number of positions eliminated for the quarter ending 2026-06-30 was 75.00 position.
- GeneDx Holdings Corp. restructuring and related cost, number of positions eliminated for fiscal 2022 was 250.00 position.
| Period end | Restructuring and Related Cost, Number of Positions Eliminated | Restructuring and Related Cost, Number of Positions Eliminated 3 month | Restructuring and Related Cost, Number of Positions Eliminated 12 month |
|---|---|---|---|
| 2026-06-30 | 75.00 position 10-Q · filed 2026-08-03 | ||
| 2023-10-30 | 35.00 position 10-K · filed 2025-02-20 | ||
| 2023-08-23 | 50.00 position 10-K · filed 2025-02-20 | ||
| 2022-12-31 | 250.00 position 10-K · filed 2024-02-23 | ||
| 2022-12-14 | 500.00 position 10-K · filed 2024-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |